Precision Biosciences DTIL
NASDAQ DTIL
$6.31 -0.02 (-0.32%)
At close: Oct 2, 2026 · 4:00 PM EDT

Precision Biosciences (DTIL) Depreciation & Amortization (CF) (2018 - 2026)

Updated

Precision Biosciences (DTIL) recorded Depreciation & Amortization (CF) of $253,000 in fiscal Q2 2026 (quarter ended Jun 30, 2026), down 33.1% from $378,000 a year earlier and down 15.4% from the prior quarter.

Analysis

Precision Biosciences (DTIL) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends

On a TTM basis, Precision Biosciences' Depreciation & Amortization (CF) came in at $1.28 million as of Jun 30, 2026, down 34.1% year-over-year; for FY2025 (ended Dec 31, 2025), it was $1.5 million, down 55.9% from FY2024.

  • Annual Depreciation & Amortization (CF) has declined for four straight fiscal years, with a five-year compound annual growth rate of -29.8% (FY2020 to FY2025).
  • Across earlier fiscal years, Depreciation & Amortization (CF) came in at $3.4 million in FY2024 (-50.1%), $6.82 million in FY2023 (-12.6%), $7.8 million in FY2022 (-13.2%) and $8.98 million in FY2021 (+2.3%).
  • The fiscal Q2 2026 figure is the lowest quarterly Depreciation & Amortization (CF) in data going back to fiscal Q1 2018.
  • On a year-over-year basis, Depreciation & Amortization (CF) has declined for 12 consecutive quarters, with an average decline of 47.1% over the last eight quarters.
  • Peak year-over-year performance for Depreciation & Amortization (CF) in the last five years was growth of 1.9% in fiscal Q2 2023, against a decline of 65.4% in fiscal Q1 2025 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $299,000 (Q1 2026), $377,000 (Q4 2025) and $350,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 1.96 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 194.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 1.93 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 98.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 1.62 Bn
10 Precision Biosciences 167.32 Mn -181.86 Mn - 253,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 253,000.00
Mar 31, 2026 299,000.00
Dec 31, 2025 377,000.00
Sep 30, 2025 350,000.00
Jun 30, 2025 378,000.00
Mar 31, 2025 395,000.00
Dec 31, 2024 454,000.00
Sep 30, 2024 715,000.00
Jun 30, 2024 1.09 Mn
Mar 31, 2024 1.14 Mn
Dec 31, 2023 1.28 Mn
Sep 30, 2023 1.62 Mn
Jun 30, 2023 1.97 Mn
Mar 31, 2023 1.95 Mn
Dec 31, 2022 1.96 Mn
Sep 30, 2022 1.94 Mn
Jun 30, 2022 1.93 Mn
Mar 31, 2022 1.97 Mn
Dec 31, 2021 2.18 Mn
Sep 30, 2021 2.26 Mn
API Access

Precision Biosciences Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=DTIL&period=max&api_key=YOUR_API_KEY